Brody M B, Reichard R A
Department of Medicine, Temple University Hospital, Philadelphia, USA.
Postgrad Med. 1995 Aug;98(2):54-6, 61-6, 68.
The ultrasensitive third-generation assay for thyrotropin (TSH) is now the "gold standard" for measuring thyroid activity. Who should be screened with it, and what further studies should be done if results are abnormal? Which patients with subclinical disease should receive treatment? Drs Brody and Reichard discuss these and other issues and provide an algorithm for thyroid screening.
超灵敏促甲状腺激素(TSH)第三代检测法现已成为衡量甲状腺活性的“金标准”。哪些人应该接受该检测筛查?如果检测结果异常,应进一步开展哪些研究?哪些亚临床疾病患者应该接受治疗?布罗迪博士和赖夏德博士讨论了这些问题及其他相关问题,并提供了一份甲状腺筛查算法。